University Communications and Press Office

When food prices skyrocket during an economic crisis, it is primarily urban populations and people with low levels of education who are affected. This can have lifelong negative health consequences – such as stunted growth in children. A research team at the University of Bonn has now demonstrated such long-term effects using the example of the "Asian financial crisis" in the 1990s. At that time, turmoil on the financial markets led to a drastic increase in the price of rice, Indonesia's most important staple food, which left measurable traces in the development of children. The study was published in the journal "Global Food Security."

From January 1, 2026, the number of clusters of excellence funded at the University of Bonn will rise to eight – more than at any other university in Germany. Two new cluster projects will receive funding from the Excellence Strategy of the German federal and state governments for the first time. Starting in 2026, a total of around 40 million euros will flow into Bonn each year to strengthen the research activities of this University of Excellence.

Two projects by researchers from the University of Bonn and University Hospital Bonn (UKB) have each been awarded up to €1 million in funding from the Federal Ministry of Research, Technology and Space’s “GO-Bio initial” program. The funds will be used to translate research findings from the life sciences into marketable products and services, e.g. through securing patent protection and spinning off start-ups.

MOG Antibody-associated Disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients contains antibodies against myelin oligodendrocyte glycoprotein (MOG), a protein in the myelin layer that surrounds the neurons in the brain. It is believed that these antibodies contribute to the destruction of this protective layer in the brain. Researchers at the University Hospital Bonn (UKB) and the Universities of Basel and Bonn, in collaboration with Yale School of Medicine and the German Center for Neurodegenerative Diseases (DZNE), have now deciphered the construction plan of the anti-MOG antibodies. The researchers see their findings on the misdirected immune response, which have now been published in the journal Neurology® Neuroimmunology & Neuroinflammation, as the basis for developing specific MOGAD therapies.